Hearing Aids Market Research Report
商品番号 : SMB-76786
| 出版社 | Market Research Future |
| 出版年月 | 2025年3月 |
| ページ数 | 134 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Market Overview
According to the MRFR analysis, the hearing aids market size was anticipated to reach USD 12,034.01 million in 2023. The hearing devices market is expected to advance at a compound annual growth rate (CAGR) of approximately 8.52% during the forecast period (2025–2032).
MRFRの分析によると、補聴器市場規模は2023年に120億3,401万米ドルに達すると予想されています。補聴装置市場は、予測期間（2025～2032年）中に約8.52%の複合年間成長率（CAGR）で成長すると予想されています。
The global market for hearing aids is expanding swiftly because of a number of fundamental variables. One of the primary causes of this trend is the increasing prevalence of hearing loss, particularly among the elderly. The demand is increasing as a result of the increased awareness of auditory health issues by governments and health organizations worldwide. Furthermore, the expansion of product offerings and the expansion of the clientele have been facilitated by technological advancements such as the development of digital hearing aides and wireless networking capabilities. The increasing disposable income of consumers in a variety of sectors will result in a greater number of individuals having access to hearing aids that can enhance their quality of life. Additionally, the process of purchasing these devices will be simplified.
Market Segmentation
Hearing implants and hearing aid devices are the two product segments that comprise the global market for hearing aids.
Based on the form of hearing loss, the global market is divided into two segments: sensorineural and conductive.
The market is divided into two segments based on the category of patient: adults and pediatrics.
Technology-wise, the global market for hearing aides is divided between analog and digital.
Technology divides the market into two segments: digital and analog.
The end-user market is divided into three segments: Medicare/Medicaid, third-party payer, and private pay/out-of-pocket.
Local Perspectives
The study provides market information for hearing aids in the following regions: North America, Europe, Asia-Pacific, and the rest of the globe. North America was the dominant force in the global market in 2023. Several factors, such as the increasing sales volume of hearing devices, the widespread adoption of less noticeable devices for greater aesthetic appeal, and the introduction of new products, are expected to contribute to North America’s maximum growth rate during the forecast period. Europe is anticipated to possess the second-largest share as a result of the substantial government support and the expansion of research into the development of state-of-the-art hearing apparatus. The strategic presence of several businesses in the region, such as GN Store Nord A/S, Senovo, Demant A/S, and WS Audiology, is also expected to contribute to growth. According to the National Institute for Health and Care Excellence (NICE), approximately 1,260 individuals in England currently receive cochlear implants each year. Furthermore, it would encourage market expansion. The aging population and the increasing use of hearing implants are expected to result in the highest compound annual growth rate (CAGR) in Asia Pacific during the projection period. According to Hear-it.org, the number of Australians with hearing loss is estimated to be 3.6 billion. This figure is expected to increase to 7.8 billion by 2060, which is expected to contribute to the nation’s economic development.
Primary Players
Some of the major players in the hearing aids market include Starkey Hearing Technologies, Signia, Oticon, Demant, GN Store Nord, Unitron, Eargo, Cochlear, WS Audiology, Rexton, MED-EL (Medical Electronics), William Demant Holding A/S, Amplifon, Sonova, Audina Hearing Instruments, Beltone, and Hearing Life.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ………………………………………………………………………………………………… 18
2 MARKET INTRODUCTION ……………………………………………………………………………………………… 20
2.1 DEFINITION ……………………………………………………………………………………………………………………………………………… 20
2.2 SCOPE OF THE STUDY ……………………………………………………………………………………………………………………………. 20
2.3 RESEARCH OBJECTIVE ………………………………………………………………………………………………………………………….. 20
3 RESEARCH METHODOLOGY ………………………………………………………………………………………… 21
3.1 OVERVIEW ……………………………………………………………………………………………………………………………………………….. 21
3.2 DATA FLOW ……………………………………………………………………………………………………………………………………………… 23
3.2.1 Data Mining Process ……………………………………………………………………………………………………………………… 23
3.3 PURCHASED DATABASE: ……………………………………………………………………………………………………………………….. 24
3.4 SECONDARY SOURCES: ………………………………………………………………………………………………………………………….. 25
3.4.1 Secondary Research data flow: ………………………………………………………………………………………………………… 26
3.5 PRIMARY RESEARCH: …………………………………………………………………………………………………………………………….. 27
3.5.1 Primary Research DATA FLOW: ……………………………………………………………………………………………………….. 28
3.5.2 Primary Research: Number of Interviews conducted ……………………………………………………………………………. 29
3.5.3 Primary Research: Regional Coverage ………………………………………………………………………………………………. 29
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ………………………………………………………………………………. 30
3.6.1 Revenue Analysis Approach ……………………………………………………………………………………………………………. 30
3.7 DATA FORECASTING………………………………………………………………………………………………………………………………. 31
3.7.1 Data forecasting Type ……………………………………………………………………………………………………………………. 31
3.8 DATA MODELING …………………………………………………………………………………………………………………………………….. 32
3.8.1 microeconomic factor analysis: ……………………………………………………………………………………………………….. 32
3.8.2 Data modeling: …………………………………………………………………………………………………………………………….. 33
3.9 TEAMS AND ANALYST CONTRIBUTION …………………………………………………………………………………………….. 35
4 MARKET DYNAMICS …………………………………………………………………………………………………….. 37
4.1 INTRODUCTION ……………………………………………………………………………………………………………………………………….. 37
4.2 DRIVERS ……………………………………………………………………………………………………………………………………………………. 37
4.2.1 Increasing Incidences of Hearing Loss ……………………………………………………………………………………………… 37
4.2.2 Growth of Elderly/Geriatric Population ………………………………………………………………………………………………. 37
4.3 RESTRAINTS ……………………………………………………………………………………………………………………………………………. 37
4.3.1 High Cost and Affordability Issues ……………………………………………………………………………………………………. 37
4.3.2 Stigma and Social Acceptance ………………………………………………………………………………………………………… 38
4.4 OPPORTUNITY …………………………………………………………………………………………………………………………………………. 38
4.4.1 Rise in Disposable Income and Affordability……………………………………………………………………………………….. 38
4.4.2 Technological Advancements ………………………………………………………………………………………………………….. 38
5 MARKET FACTOR ANALYSIS ………………………………………………………………………………………… 39
5.1 PORTER’S FIVE FORCES MODEL …………………………………………………………………………………………………………… 39
5.1.1 Porter’s Five Forces Model ……………………………………………………………………………………………………………… 39
5.1.1.1 Threat of New Entrants …………………………………………………………………………………………………………… 39
5.1.1.2 Bargaining Power of Suppliers …………………………………………………………………………………………………. 40
5.1.1.3 Bargaining Power of Buyers …………………………………………………………………………………………………….. 40
5.1.1.4 Threat of Substitutes ……………………………………………………………………………………………………………… 40
5.1.1.5 Industry Rivalry ……………………………………………………………………………………………………………………… 41
5.2 IMPACT OF COVID-19 ON HEARING AIDS MARKET …………………………………………………………………………… 41
5.3 OTC HEARING AID MARKET TRENDS …………………………………………………………………………………………………. 41
5.4 PAYMENT MODE ANALYSIS BY REGION ……………………………………………………………………………………………. 43
6 GLOBAL HEARING AIDS MARKET, BY PRODUCT …………………………………………………………… 48
6.1 INTRODUCTION ……………………………………………………………………………………………………………………………………….. 48
6.1.1 Hearing Aid Devices ………………………………………………………………………………………………………………………. 48
6.1.1.1 Behind-the-ear (BTE) Hearing Aids …………………………………………………………………………………………….. 48
6.1.1.2 In-the-ear (ITE) Hearing Aids ……………………………………………………………………………………………………. 48
6.1.1.3 Canal Hearing Aids ………………………………………………………………………………………………………………… 48
6.1.1.4 Receiver-in-the-ear (RIE) Hearing Aid …………………………………………………………………………………………. 48
6.1.1.5 Others …………………………………………………………………………………………………………………………………. 48
6.1.2 Hearing Implants ………………………………………………………………………………………………………………………….. 48
6.1.2.1 Cochlear Implants …………………………………………………………………………………………………………………. 49
6.1.2.2 Bone-Anchored Hearing Aids (BAHA) ………………………………………………………………………………………… 49
7 GLOBAL HEARING AIDS MARKET, BY TYPE OF HEARING LOSS …………………………………….. 51
7.1 INTRODUCTION ……………………………………………………………………………………………………………………………………….. 51
7.1.1 Sensorineural Hearing Loss…………………………………………………………………………………………………………….. 51
7.1.2 Conductive Hearing Loss ……………………………………………………………………………………………………………….. 51
8 GLOBAL HEARING AIDS MARKET, BY PATIENT TYPE …………………………………………………….. 53
8.1 INTRODUCTION ……………………………………………………………………………………………………………………………………….. 53
8.1.1 Adults ………………………………………………………………………………………………………………………………………… 53
8.1.2 Pediatrics ……………………………………………………………………………………………………………………………………. 53
9 GLOBAL HEARING AIDS MARKET, BY TECHNOLOGY …………………………………………………….. 55
9.1 INTRODUCTION ……………………………………………………………………………………………………………………………………….. 55
9.1.1 Digital ………………………………………………………………………………………………………………………………………… 55
9.1.2 Analog ……………………………………………………………………………………………………………………………………….. 55
10 GLOBAL HEARING AIDS MARKET, BY END USER ………………………………………………………….. 57
10.1 INTRODUCTION ……………………………………………………………………………………………………………………………………….. 57
10.1.1 Private Pay/Out of Pocket ………………………………………………………………………………………………………………. 57
10.1.2 Third Party Payer ………………………………………………………………………………………………………………………….. 57
10.1.3 Medicare/Medicaid ……………………………………………………………………………………………………………………….. 57
11 GLOBAL HEARING AIDS MARKET, BY REGION ………………………………………………………………. 59
11.1 INTRODUCTION ……………………………………………………………………………………………………………………………………….. 59
11.1.1 North America ……………………………………………………………………………………………………………………………… 60
11.1.1.1 US ……………………………………………………………………………………………………………………………………… 62
11.1.1.2 Canada ……………………………………………………………………………………………………………………………….. 64
11.1.1.3 Mexico ……………………………………………………………………………………………………………………………….. 65
11.1.2 EUROPE ……………………………………………………………………………………………………………………………………… 67
11.1.2.1 Germany ……………………………………………………………………………………………………………………………… 69
11.1.2.2 UK ……………………………………………………………………………………………………………………………………… 71
11.1.2.3 France ………………………………………………………………………………………………………………………………… 72
11.1.2.4 Italy ……………………………………………………………………………………………………………………………………. 74
11.1.2.5 Spain ………………………………………………………………………………………………………………………………….. 76
11.1.2.6 Rest Of Europe ……………………………………………………………………………………………………………………… 77
11.1.3 ASIA-PACIFIC ………………………………………………………………………………………………………………………………. 79
11.1.3.1 Japan …………………………………………………………………………………………………………………………………. 81
11.1.3.2 China ………………………………………………………………………………………………………………………………….. 83
11.1.3.3 India …………………………………………………………………………………………………………………………………… 84
11.1.3.4 Australia ……………………………………………………………………………………………………………………………… 86
11.1.3.5 Rest Of Asia Pacific ……………………………………………………………………………………………………………….. 88
11.1.4 SOUTH AMERICA ………………………………………………………………………………………………………………………….. 89
11.1.4.1 Brazil ………………………………………………………………………………………………………………………………….. 91
11.1.4.2 Colombia …………………………………………………………………………………………………………………………….. 93
11.1.4.3 Rest of South America ……………………………………………………………………………………………………………. 95
11.1.5 Middle East & Africa ……………………………………………………………………………………………………………………… 97
11.1.5.1 South Africa …………………………………………………………………………………………………………………………. 99
11.1.5.2 GCC Countries ………………………………………………………………………………………………………………………. 101
11.1.5.3 Rest of Middle East and Africa …………………………………………………………………………………………………. 103
12 COMPETITIVE LANDSCAPE ………………………………………………………………………………………….. 105
12.1 INTRODUCTION ……………………………………………………………………………………………………………………………………….. 105
12.2 MARKET SHARE ANALYSIS, 2023 ……………………………………………………………………………………………………….. 105
13 COMPANY PROFILES …………………………………………………………………………………………………… 106
13.1 COCHLEAR LIMITED ……………………………………………………………………………………………………………………………….. 106
13.1.1 COMPANY OVERVIEW ……………………………………………………………………………………………………………………. 106
13.1.2 PRODUCTS OFFERed……………………………………………………………………………………………………………………… 106
13.1.3 SWOT ANALYSIS ………………………………………………………………………………………………………………………….. 107
13.1.4 Key Strategy ………………………………………………………………………………………………………………………………… 107
13.2 GN HEARING A/S …………………………………………………………………………………………………………………………………….. 108
13.2.1 COMPANY OVERVIEW ……………………………………………………………………………………………………………………. 108
13.2.2 PRODUCTS OFFERed……………………………………………………………………………………………………………………… 108
13.2.3 SWOT ANALYSIS ………………………………………………………………………………………………………………………….. 109
13.2.4 Key Strategy ………………………………………………………………………………………………………………………………… 110
13.3 SONOVA ……………………………………………………………………………………………………………………………………………………. 111
13.3.1 COMPANY OVERVIEW ……………………………………………………………………………………………………………………. 111
13.3.2 PRODUCTS OFFERed……………………………………………………………………………………………………………………… 112
13.3.3 SWOT ANALYSIS ………………………………………………………………………………………………………………………….. 113
13.3.4 Key Strategy ………………………………………………………………………………………………………………………………… 113
13.4 WILLIAM DEMANT HOLDING A/S ………………………………………………………………………………………………………… 114
13.4.1 COMPANY OVERVIEW ……………………………………………………………………………………………………………………. 114
13.4.2 PRODUCTS OFFERed……………………………………………………………………………………………………………………… 115
13.4.3 SWOT ANALYSIS ………………………………………………………………………………………………………………………….. 116
13.4.4 Key Strategy ………………………………………………………………………………………………………………………………… 117
13.5 STARKEY ………………………………………………………………………………………………………………………………………………….. 118
13.5.1 COMPANY OVERVIEW ……………………………………………………………………………………………………………………. 118
13.5.2 PRODUCTS OFFERed……………………………………………………………………………………………………………………… 118
13.5.3 SWOT ANALYSIS ………………………………………………………………………………………………………………………….. 120
13.5.4 Key Strategy ………………………………………………………………………………………………………………………………… 120
13.6 PETROFAC ………………………………………………………………………………………………………………………………………………… 121
13.6.1 COMPANY OVERVIEW ……………………………………………………………………………………………………………………. 121
13.6.2 PRODUCTS OFFERed……………………………………………………………………………………………………………………… 121
13.6.3 SWOT ANALYSIS ………………………………………………………………………………………………………………………….. 122
13.6.4 Key Strategy ………………………………………………………………………………………………………………………………… 122
13.7 HALLIBURTON…………………………………………………………………………………………………………………………………………. 123
13.7.1 COMPANY OVERVIEW ……………………………………………………………………………………………………………………. 123
13.7.2 PRODUCTS OFFERed……………………………………………………………………………………………………………………… 123
13.7.3 SWOT ANALYSIS ………………………………………………………………………………………………………………………….. 124
13.7.4 Key Strategy ………………………………………………………………………………………………………………………………… 124
13.8 ZOUNDS HEARING …………………………………………………………………………………………………………………………………… 125
13.8.1 COMPANY OVERVIEW ……………………………………………………………………………………………………………………. 125
13.8.2 PRODUCTS OFFERed……………………………………………………………………………………………………………………… 125
13.8.3 SWOT ANALYSIS ………………………………………………………………………………………………………………………….. 126
13.8.4 Key Strategy ………………………………………………………………………………………………………………………………… 127
13.9 AUDINA HEARING INSTRUMENTS………………………………………………………………………………………………………. 127
13.9.1 COMPANY OVERVIEW ……………………………………………………………………………………………………………………. 127
13.9.2 PRODUCTS OFFERed……………………………………………………………………………………………………………………… 128
13.9.3 SWOT ANALYSIS ………………………………………………………………………………………………………………………….. 128
13.9.4 Key Strategy ………………………………………………………………………………………………………………………………… 129
13.10 AMPLIFON ……………………………………………………………………………………………………………………………………………….. 130
13.10.1 COMPANY OVERVIEW ……………………………………………………………………………………………………………………. 130
13.10.2 PRODUCTS OFFERed……………………………………………………………………………………………………………………… 130
13.10.3 SWOT ANALYSIS ………………………………………………………………………………………………………………………….. 130
13.10.4 Key Strategy ………………………………………………………………………………………………………………………………… 131
14 DATA CITATIONS …………………………………………………………………………………………………………. 132
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 33
TABLE 2 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 49
TABLE 3 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 50
TABLE 4 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 50
TABLE 5 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 51
TABLE 6 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 53
TABLE 7 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 55
TABLE 8 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 58
TABLE 9 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY REGION, 2018–2032 (USD MILLION) 59
TABLE 10 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 60
TABLE 11 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 60
TABLE 12 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 60
TABLE 13 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 61
TABLE 14 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 61
TABLE 15 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 61
TABLE 16 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 61
TABLE 17 US HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 62
TABLE 18 US HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 62
TABLE 19 US HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 62
TABLE 20 US HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 62
TABLE 21 US HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 63
TABLE 22 US HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 63
TABLE 23 US HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 63
TABLE 24 CANADA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 64
TABLE 25 CANADA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 64
TABLE 26 CANADA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 64
TABLE 27 CANADA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 64
TABLE 28 CANADA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 65
TABLE 29 CANADA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 65
TABLE 30 CANADA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 65
TABLE 31 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 65
TABLE 32 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 66
TABLE 33 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 66
TABLE 34 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 66
TABLE 35 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 66
TABLE 36 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 67
TABLE 37 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 67
TABLE 38 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 67
TABLE 39 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 67
TABLE 40 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 68
TABLE 41 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 68
TABLE 42 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 68
TABLE 43 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 68
TABLE 44 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 68
TABLE 45 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 69
TABLE 46 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 69
TABLE 47 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 69
TABLE 48 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 70
TABLE 49 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 70
TABLE 50 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 70
TABLE 51 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 70
TABLE 52 UK HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 71
TABLE 53 UK HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 71
TABLE 54 UK HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 71
TABLE 55 UK HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 71
TABLE 56 UK HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 72
TABLE 57 UK HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 72
TABLE 58 UK HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 72
TABLE 59 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 72
TABLE 60 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 73
TABLE 61 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 73
TABLE 62 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 73
TABLE 63 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 73
TABLE 64 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 74
TABLE 65 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 74
TABLE 66 ITALY HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 74
TABLE 67 ITALY HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 74
TABLE 68 ITALY HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 75
TABLE 69 ITALY HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 75
TABLE 70 ITALY HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 75
TABLE 71 ITALY HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 75
TABLE 72 ITALY HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 75
TABLE 73 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 76
TABLE 74 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 76
TABLE 75 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 76
TABLE 76 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 76
TABLE 77 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 77
TABLE 78 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 77
TABLE 79 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 77
TABLE 80 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 77
TABLE 81 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 78
TABLE 82 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 78
TABLE 83 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 78
TABLE 84 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 78
TABLE 85 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 79
TABLE 86 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 79
TABLE 87 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 79
TABLE 88 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 79
TABLE 89 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 80
TABLE 90 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 80
TABLE 91 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 80
TABLE 92 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 80
TABLE 93 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 81
TABLE 94 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 81
TABLE 95 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 81
TABLE 96 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 81
TABLE 97 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 82
TABLE 98 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 82
TABLE 99 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 82
TABLE 100 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 82
TABLE 101 CHINA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 83
TABLE 102 CHINA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 83
TABLE 103 CHINA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 83
TABLE 104 CHINA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 83
TABLE 105 CHINA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 84
TABLE 106 CHINA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 84
TABLE 107 CHINA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 84
TABLE 108 INDIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 84
TABLE 109 INDIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 84
TABLE 110 INDIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 85
TABLE 111 INDIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 85
TABLE 112 INDIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 85
TABLE 113 INDIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 85
TABLE 114 INDIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 85
TABLE 115 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 86
TABLE 116 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 86
TABLE 117 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 86
TABLE 118 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 86
TABLE 119 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 87
TABLE 120 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 87
TABLE 121 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 87
TABLE 122 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 88
TABLE 123 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 88
TABLE 124 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 88
TABLE 125 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 88
TABLE 126 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 89
TABLE 127 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 89
TABLE 128 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 89
TABLE 129 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 89
TABLE 130 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 89
TABLE 131 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 90
TABLE 132 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 90
TABLE 133 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 90
TABLE 134 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 91
TABLE 135 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 91
TABLE 136 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 91
TABLE 137 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 91
TABLE 138 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 91
TABLE 139 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 92
TABLE 140 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 92
TABLE 141 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 92
TABLE 142 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 92
TABLE 143 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 93
TABLE 144 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 93
TABLE 145 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 93
TABLE 146 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 93
TABLE 147 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 94
TABLE 148 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 94
TABLE 149 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 94
TABLE 150 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 95
TABLE 151 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 95
TABLE 152 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 95
TABLE 153 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 95
TABLE 154 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 96
TABLE 155 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 96
TABLE 156 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 96
TABLE 157 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 97
TABLE 158 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 97
TABLE 159 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 97
TABLE 160 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 97
TABLE 161 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 98
TABLE 162 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 98
TABLE 163 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 98
TABLE 164 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 99
TABLE 165 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 99
TABLE 166 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 99
TABLE 167 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 99
TABLE 168 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 100
TABLE 169 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 100
TABLE 170 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 100
TABLE 171 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 101
TABLE 172 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 101
TABLE 173 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 101
TABLE 174 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 101
TABLE 175 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 102
TABLE 176 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 102
TABLE 177 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 102
TABLE 178 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 103
TABLE 179 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 103
TABLE 180 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 103
TABLE 181 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 103
TABLE 182 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 104
TABLE 183 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 104
TABLE 184 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 104
TABLE 185 COCHLEAR LIMITED COMPANY: PRODUCTS OFFERED 106
TABLE 186 GN HEARING A/S: PRODUCTS OFFERED 108
TABLE 187 SONOVA: PRODUCTS OFFERED 112
TABLE 188 WILLIAM DEMANT HOLDING A/S.: PRODUCTS OFFERED 115
TABLE 189 STARKEY: PRODUCTS OFFERED 118
TABLE 190 PETROFAC PRODUCTS OFFERED 121
TABLE 191 HALLIBURTON PRODUCTS OFFERED 123
TABLE 192 ZOUNDS HEARING PRODUCTS OFFERED 125
TABLE 193 AUDINA HEARING INSTRUMENTS PRODUCTS OFFERED 128
TABLE 194 AUDINA HEARING INSTRUMENTS PRODUCTS OFFERED 130
LIST OF FIGURES
FIGURE 1 GLOBAL HEARING AIDS MARKET, BY PRODUCT, 2023 (% SHARE) 49
FIGURE 2 GLOBAL HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2023 (% SHARE) 52
FIGURE 3 GLOBAL HEARING AIDS MARKET, BY PATIENT TYPE, 2023 (% SHARE) 54
FIGURE 4 GLOBAL HEARING AIDS MARKET, BY TECHNOLOGY, 2023 (% SHARE) 56
FIGURE 5 GLOBAL HEARING AIDS MARKET, BY END USER, 2023 (% SHARE) 58
FIGURE 6 GLOBAL HEARING AIDS MARKET MAJOR PLAYERS MARKET SHARE ANALYSIS, 2023 (%) 105
FIGURE 7 COCHLEAR LIMITED COMPANY: SWOT ANALYSIS 107
FIGURE 8 GN HEARING A/S: SWOT ANALYSIS 109
FIGURE 9 SONOVA: SWOT ANALYSIS 113
FIGURE 10 WILLIAM DEMANT HOLDING A/S.: SWOT ANALYSIS 116
FIGURE 11 STARKEY: SWOT ANALYSIS 120
FIGURE 12 PETROFAC SWOT ANALYSIS 122
FIGURE 13 HALLIBURTON SWOT ANALYSIS 124
FIGURE 14 ZOUNDS HEARING SWOT ANALYSIS 126
FIGURE 15 AUDINA HEARING INSTRUMENTS SWOT ANALYSIS 128
FIGURE 16 AUDINA HEARING INSTRUMENTS SWOT ANALYSIS 130
Market Research Future（マーケットリサーチフューチャー）はインドに主拠点を置き、技術的および経済的進歩に関して貴重な分析とデータを提供しています。調査結果にはMarket Research Futureのアナリストが直接著名な市場プレーヤーから入手した関連情報も含まれています。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
パターン1
| シングルユーザ | マルチユーザ | エンタープライズサイト |
| USD4,950 | USD5,950 | USD7,250 |
パターン2
| シングルユーザ | マルチユーザ | エンタープライズサイト |
| USD2,950 | USD3,950 | USD 5,250 |
ご購入に関するご案内
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。
- 手数料はいただいておりません。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルの閲覧・レポート内容の利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連企業除く）10名までレポートファイルのご共有可能です。
- エンタープライズワイドライセンス
- 同一企業であれば、人数無制限でレポートファイルの閲覧・レポート内容の利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後2営業日以内
- その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
レポートの詳細、価格、購入等に関するご質問はいつでもお気軽にお問合せください。
最新調査レポート
